Citurgia Biochemicals last traded at ₹18.00 (2026-10-13). Over the past month the stock moved -83.1%, three months the stock moved -84.5%. Its closing range over 52 weeks is ₹18.00 – ₹184.50, with the latest close 90.2% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1969, Citurgia Biochemicals Ltd deals in the manufacturing and trading of citric acid.[1]
Business Overview:[1] CBCL manufactures, processes, and trades citric acid, calcium carbonate, and plasticizers. Citric acid is used in foods, soft drinks, confectionery, pharmaceuticals, and industrial chemicals to provide stable pH conditions for polyester, nylon, acrylic print curing, and cotton-resist printing.
In the latest quarter (Jun 2026), Citurgia Biochemicals reported sales of ₹0.00 crore and net profit of ₹-0.08 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 0.00 | -0.03 | – | -0.08 | -0.01 |
| Mar 2026 | 0.00 | -0.20 | – | -0.26 | -0.02 |
| Dec 2025 | 0.00 | -0.23 | – | -0.29 | -0.02 |
| Sep 2025 | 0.00 | -0.05 | – | -0.11 | -0.01 |
| Jun 2025 | 0.00 | -0.03 | – | -0.08 | -0.01 |
| Mar 2025 | 0.00 | -0.06 | – | -0.12 | -0.01 |
| Dec 2024 | 0.00 | -0.05 | – | -0.10 | -0.01 |
| Sep 2024 | 0.00 | -0.08 | – | -0.14 | -0.01 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | – | – | – | – | – | – | – |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | – | – | – | – |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | – | – | – | – | – | – | – | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Citurgia Biochemicals reported sales of ₹0.00 crore and net profit of ₹-0.74 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 0.00 | -0.52 | – | -0.74 | -0.06 |
| Mar 2025 | 0.00 | -0.20 | – | -0.42 | -0.03 |
| Mar 2024 | 0.00 | -0.25 | – | -0.48 | -0.04 |
| Mar 2023 | 0.00 | -0.21 | – | -0.44 | -0.03 |
| Mar 2022 | 0.00 | -0.18 | – | -0.40 | -0.03 |
| Mar 2021 | 0.00 | -0.37 | – | -0.61 | -0.05 |
| Mar 2020 | 0.00 | -0.12 | – | -0.40 | -0.03 |
| Mar 2019 | 0.00 | -0.24 | – | -0.56 | -0.04 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | – | – | – | – | – | – | – |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | – | – | – | – |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | – | – | – | – | – | – | – | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Citurgia Biochemicals.
Get Free AI Stock Analysis FREE →Citurgia Biochem. reports Profit after tax of Rs -0.83 Mln, in the June 2026 quarter
Citurgia Biochemicals shares were last quoted at ₹18.00 (+2.3% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Citurgia Biochemicals has a price-to-earnings (P/E) ratio of -1,758.33 and a price-to-book (P/B) ratio of 0.00. The industry P/E is 43.49.
The 52-week high of Citurgia Biochemicals is ₹212.00 and the 52-week low is ₹47.40.
The market capitalisation of Citurgia Biochemicals is about ₹1,393.61 crore.
In the latest quarter (Jun 2026), Citurgia Biochemicals reported sales of ₹0.00 crore and net profit of ₹-0.08 crore, compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Citurgia Biochemicals has 3-year profit growth of -32.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 99.36% of Citurgia Biochemicals.
Citurgia Biochemicals belongs to the Chemicals sector.